Effect of Remote Ischemic Conditioning on Neutrophil Function and the Immune-Inflammatory and Coagulation Profiles in Trauma Patients With Hemorrhagic Shock
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 50
- 试验地点
- 2
- 主要终点
- Neutrophil Oxidative Burst Activity
研究概览
简要总结
The purpose of the study is to evaluate whether remote ischemic conditioning is a safe and effective intervention to prevent the development of inflammation and coagulopathy in trauma patients with hemorrhagic shock.
详细描述
Dysfunction of vital organs is one of the major reasons why trauma victims die after sustaining a major injury, even though the organs themselves may not have been directly injured. The inability to clot blood as a result of inflammation further contributes to complications in a majority of these patients. One intervention proposed to protect against impaired organ function is called "Remote Ischemic Conditioning", wherein application of intermittent occlusion and release of blood flow to the arm by sequentially inflating and deflating a blood pressure cuff can protect against the development of distant organ injury and inflammation following a severe traumatic event. In a pilot study, we will investigate the effects of remote ischemic conditioning in trauma patients with hemorrhagic shock, with a view to evaluate its effects on the immune system and coagulation profiles, both of which are known to be deranged in these patients. These studies will potentially benefit patients and will serve as a proof of principle for the use of remote ischemic conditioning in the trauma setting.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 16 Years 至 —(Child, Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age ≥16 years of age or estimated weight ≥50kgs if age is unknown;
- •Victim of blunt or penetrating trauma
- •Hemorrhagic shock defined as:
- •One or more episodes of systolic blood pressure ≤90mmHg at any time prior to enrollment into the study;
- •An identified source of blood loss (abdomen, chest, pelvis/retroperitoneum, extremities, external) or
- •Blood products (RBC, Platelets, Plasma, etc.) has been ordered to the trauma room.
- •Admitted to St. Michael's Hospital directly from the scene of injury within 3 hours of the injury
- •Application and completion of Remote Ischemic Conditioning (RIC) within 4 hours of the injury
排除标准
- •Pregnancy
- •Non-hemorrhagic shock (i.e. tension pneumothorax, cardiac tamponade, spinal shock, etc.)
- •Major burns > 20% total body surface area
- •Fracture of both lower extremities (i.e. traumatic amputation, fractures)
- •Absence of vital signs prior to admission, ongoing CPR, possibly dead on admission or not expected to survive beyond a few hours.
- •Injury in both legs (traumatic amputation, fractures, etc.)
- •Patients with a systolic blood pressure above 200mmHg
- •Patients treated with anticoagulants, antiplatelet therapy (Warfarin, Aspirin), steroids or with a known bleeding disorder or known abnormality of blood flow to the limb (if known)
- •Patients with osteoporosis or other bone disorders, peripheral nerve injury, abnormal nerve supply, peripheral neuropathy (if known) or preexisting traumatic injury to the limb.
- •Morbid obesity (largest cuff size won't fit)
- •If RIC is done clinically before research protocol begins.
结局指标
主要结局
Neutrophil Oxidative Burst Activity
时间窗: 0 (Admission), 1, 3, and 24 hours after intervention
Change in neutrophil oxidative burst activity (dihydrorhodamine, DHR) over 24 hours from admission. Measured by flow cytometry using whole blood samples.
Neutrophil Oxidative Burst Activity (PMA Stimulated)
时间窗: 0 (Admission), 1, 3, and 24 hours after intervention
Change in PMA stimulated neutrophil oxidative burst activity (dihydrorhodamine, DHR) over 24 hours. Measured by flow cytometry using whole blood samples.
Neutrophil Adhesion Molecule Expression (CD11b)
时间窗: 0 (Admission), 1, 3, 24 hours after intervention
Change in neutrophil adhesion molecule (CD11b) expression over 24 hours from admission. Measured by flow cytometry using whole blood samples.
Neutrophil Adhesion Molecule Expression (CD62L)
时间窗: 0 (Admission), 1, 3, and 24 hours after intervention
Change in neutrophil adhesion molecule (CD62L) expression over 24 hours from admission. Measured by flow cytometry using whole blood samples.
Endothelial Injury (Heparan Sulfate)
时间窗: 0 (Admission), 1, 3, and 24 hours after intervention
Change in plasma levels of endothelial injury marker Heparan Sulfate over 24 hours from Admission
Endothelial Injury (Hyaluronan)
时间窗: 0 (Admission), 1, 3, 24 hours
Change in plasma levels of endothelial injury marker Hyaluronan over 24 hours from Admission
Plasma TNF-α
时间窗: 0 (Admission), 1, 3, and 24 hours after intervention
Change in plasma levels of inflammatory mediator TNF-α over 24 hours from Admission
Plasma IL-8
时间窗: 0 (Admission), 1, 3, 24 hours
Change in plasma levels of inflammatory mediator IL-8 over 24 hours from Admission
Endothelial Injury (Syndecan-1)
时间窗: 0 (Admission), 1, 3, and 24 hours after intervention
Change in plasma levels of endothelial injury marker Syndecan-1 over 24 hours from Admission
Plasma IL-6
时间窗: 0 (Admission), 1, 3, 24 hours
Change in plasma levels of inflammatory mediator IL-6 over 24 hours from Admission
ROTEM EXTEM CFT
时间窗: 0 (Admission), 1, 3, 24 hours
Change in ROTEM parameter Clot Formation Time (CFT) over 24 hours from Admission
Plasma Fibrinogen
时间窗: 0 (Admission), 1, 3, 24 hours
Change in plasma fibrinogen levels over 24 hours from Admission
Plasma IL-10
时间窗: 0 (Admission), 1, 3, 24 hours
Change in plasma levels of anti-inflammatory mediator IL-10 over 24 hours from Admission
ROTEM EXTEM CT
时间窗: 0 (Admission), 1, 3, 24 hours
Change in ROTEM parameter Clotting Time (CT) over 24 hours from Admission
ROTEM EXTEM A10
时间窗: 0 (Admission), 1, 3, 24 hours
Change in ROTEM parameter A10 over 24 hours from Admission
ROTEM EXTEM Alpha Angle
时间窗: 0 (Admission), 1, 3, 24 hours
Change in ROTEM parameter Alpha Angle over 24 hours from Admission
ROTEM EXTEM ML
时间窗: 0 (Admission), 1, 3, 24 hours
Change in ROTEM parameter maximum lysis (ML) over 24 hours from Admission
Plasma D-Dimer
时间窗: 0 (Admission), 1, 3, 24 hours
Change in plasma D-Dimer levels over 24 hours from Admission
Plasma Protein C
时间窗: 0 (Admission), 1, 3, 24 hours
Change in plasma Protein C levels over 24 hours from Admission
次要结局
- 28 Day Mortality(up to 28 days or discharge)
- 24 Hour Mortality(up to 28 days or discharge)
- Ventilator Free Days(up to 28 days or discharge)
- ICU Free Days(up to 28 days or discharge)
- Hospital Free Days(up to 28 days or discharge)
- Nosocomial Infections(up to 28 days or discharge)
